Fractyl Health, Inc.
GUTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001572616
In the last 90 days, Fractyl Health, Inc. insiders filed 1 open-market purchase and 0 sales; 77 institutions reported holding it in 13F filings for Q2 2026, worth $56.2M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Fractyl Health, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 83
- −11 vs. Q4 2025
- Shares held
- 72.0M
- −29.7M (−29.2%) vs. Q4 2025
- Total value
- $33.0M
- −$190.8M (−85.3%) vs. Q4 2025
- New holders
- 19
- 14 more added
- Sold out
- 30
- 27 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GUTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $56.2M |
| Q1 2026 | 83 | $33.0M |
| Q4 2025 | 97 | $247.3M |
| Q3 2025 | 74 | $145.4M |
| Q2 2025 | 62 | $44.9M |
| Q1 2025 | 65 | $29.7M |
| Q4 2024 | 65 | $53.4M |
| Q3 2024 | 61 | $65.4M |
| Q2 2024 | 44 | $116.9M |
| Q1 2024 | 42 | $185.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Fractyl Health, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −117,631−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −69,427−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −60,219−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −49,137−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −38,700−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −36,300−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −35,076−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −18,006−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −17,419−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −14,768−100.0% | Sold out |
| Millington Financial Advisors, LLC | 0 | $0 | 0.00% | −12,562−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| HCC Manager LLC | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |